Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neural Transmission
Metadata
Title
Cognitive and behavioral dysfunction in Parkinson’s disease: neurochemical and clinicopathological contributions
Authors
D. J. Zgaljardic
N. S. Foldi
J. C. Borod
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Journal of Neural Transmission / Issue 10-11/2004
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-004-0178-z

Other articles of this Issue 10-11/2004

Journal of Neural Transmission 10-11/2004 Go to the issue

OriginalPaper

Antiapoptotic effects of budipine

OriginalPaper

Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease

OriginalPaper

Preface – Special Issue: A Tribute for Prof. Dr. Melvin D. Yahr, M.D. (1917–2004)

OriginalPaper

Nicotinic receptors and cognition in Parkinson’s Disease: the importance of neuronal synchrony

OriginalPaper

Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson’s disease (MSPD)

OriginalPaper

Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration